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Abstract-Effects
of N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl) acetamide (DM-9384) on learning and memory were studied using four different experimental rat models.
In electroconvulsive shock or scopolamine-induced amnesia in the step-through passive avoidance task, DM-9384 improved both types of amnesia when administered before the training trial. Aniracetam also showed similar but somewhat weaker effects.
Furthermore, in the scopolamine amnesia mode!, an improvement was confirmed with arecoline.
The dose-response curves for these compounds were bell-shaped.
In the shuttle box active avoidance task, DM-9384 administered daily 1 hr before each training session facilitated the acquisition process of the avoidance response.
In addition, the experiment of light-dark discrimi nation task with positive reinforcement showed that this compound administered daily after each session slightly accelerated the acquisition process of the correct response.
These results suggest an ability of DM-9384 to enhance cognitive functions.
The search for new drugs that improve impaired cognitive functions resulting from cerebral deficiencies such as senile dementia of the Alzheimer type or cerebral vascular disorder has been accelerated by a world wide rapid increase in the aged population. (N-(2,6-dimethylphenyl)-2-(2 oxo-1-pyrrolidinyl) acetamide, Fig. 1 ) is a new pyrrolidone derivative. A preliminary report
(1) revealed that it antagonized hypobaric or NaN02-induced hypoxia and ameliorated electroconvulsive shock-induced amnesia in mice. These results suggest that this compound may have an improving effect on learning and memory. In the present study, we examined the effect of DM-9384 in more detail on 1) tasks in rats with deficits of cognitive function, such as electroconvulsive shock and scopolamine-induced impaired passive avoidance learning, and 2) the ability of normal rats to learn more complicated tasks such as the active avoidance response and light-dark discrimination learning with positive reinforcement.
Materials and Methods
Animals: Male Wistar rats were purchased from Shizuoka Laboratory Animal Center. The rats were housed in a room with controlled temperature (23±2 °C), relative humidity (55±15%) and a 12-hr light-dark cycle (light period: 7:00-19:00).
Compounds: DM-9384 and the reference compound aniracetam were synthesized at our research institute. Both compounds were suspended in 0.5% sodium carboxymethyl cellulose (CIVIC) and administered p.o. in a volume of 0.5 m!/100 g. Arecoline hy drochloride and scopolamine hydrobromide were purchased from Tokyo Chemical Industry, Co., Ltd. and Nakarai Chemicals Co., Ltd., respectively. These drugs dissolved in physiological saline were injected i.p. and their doses were expressed in terms of the salt.
Passive avoidance response failure induced by electroconvulsive shock: The test ap paratus consisted of a two compartment box with a guillotine door between the com partments. The small unshocked compartment (15 x 10 x 12 cm) was illuminated with a 1 5 W bulb. The shock compartment was a large dark box (30x30x28 cm). The floor was made of metal rods, 1.3 cm apart, through which a foot shock (1 mA) was delivered using an electric scrambler (Lehigh Valley Electronics). Test compounds were given 1 hr before training. The training procedure was as follows: At first the rat was placed in the small compartment.
After 30 sec, the door was opened, and the latency for the animals to enter the dark compartment was recorded. Then the door was closed and a foot shock was administered for 10 sec. Immediately after the removal of the rat from the dark com partment, an electroconvulsive shock (30 mA, 0.2 sec) was delivered through the eyes by means of a corneal electrode.
The test trial was performed 24 hr after training in the same manner as described above, except that neither foot shock nor electroshock was given. The criterion was whether the animals remained in the small compartment for at least 120 sec. The results were expressed as the percent of animals per group that showed a step-latency of 120 sec and more. The animals were divided into three groups con sisting of 15 animals each (170-230 g, 7-9 weeks old). One group served as a control and the remaining groups received either DM 9384 or aniracetam. For evaluating the dose effect relationship, the data from each control group obtained on a separate day were pooled.
Passive avoidance response failure induced by scopolamine:
The test apparatus and testing procedure were the same as described in the electroconvulsive shock-induced model, although scopolamine was adminis tered either 15 min before, immediately after training or 15 min before the test trial. DM 9384 and aniracetam were given p.o. 1 hr before training. Arecoline was administered i.p. 20 min before training. Shuttle box active avoidance task: The apparatus was a shuttle box (O'Hara & Co., Ltd.). Each animal was subjected to a session consisting of 30 trials for 10 consecutive days. The conditioning stimulus used was a light (2.4 W) for 5 sec, and this was followed by a foot shock (64 V, 0.5 mA, AC) as uncondi tioned stimulus via the grid floor for 5 sec. Moving to another compartment within the presentation of the conditioned stimulus was defined as the avoidance response. The intertrial interval was 30 sec. The number of shuttle responses excluding avoidance re sponses was also recorded. The experiments were carried out in a dim lighted and sound attenuated box. DM-9384 or 0.5% CIVIC was administered 1 hr before each session. In the DM-9384-treated group, the medication was substituted by vehicle administration for this drug from the 8th to 10th sessions. Ten to 12 animals weighing 160-210 g (7-9 weeks old) were used in each group.
Light-dark discrimination learning with positive reinforcement:
The apparatus used was a Skinner box (Lehigh Valley Electro nics) equipped with a lever, a food dispenser and a small white lamp located on the same panel.
Rats were maintained on limited feeding to keep their body weight 80-85% of that at the start of the experiment (300-340 g, 14-15 weeks old). The experimental schedule was as follows: Each food-deprived rat was trained to press a lever for a food pellet (45 mg, Muromachi Kikai Co., Ltd.) in the dim lighted and sound attenuated box. In the several early sessions of the magazine con ditioning, each lever-pressing was reinforced (continuous reinforcement schedule, CRF). Animals were trained until they showed a stable response (40-50 responses) in a 10 min experimental period. Animals that ful filled the criterion were subjected to the light dark discrimination task in which the small lamp was on and off in a 30-sec cycle. Each session consisted of 10 min per day, and the animals were submitted to this schedule for a consecutive 20 days. Each lever press in a light period was reinforced with a pellet. This response was defined as a correct response, and a lever press in a dark period was not reinforced (incorrect response) . Percent correct response rate was calculated according to the following formula: (number of correct response/number of total response) x100. DM-9384 or vehicle was administered daily immediately after the 6th to the last sessions of the magazine training, and the entire period of light-dark sessions. Six rats were used in each group.
Statistical analysis: The significance of difference in % retention between the control and medicated groups was analyzed by the Fisher exact probability test. For comparison of the mean value, Student's t-test or one way analysis of variance and multiple com parison by the Dunnett or Scheffe test were used.
Results
Passive avoidance response failure induced by electroconvulsive shock: An electro convulsive shock applied immediately after the training trial produced a significant reduction in both % retention and latency lasting for more than 2 weeks, compared with those of the nonelectroconvulsive shock group. However, when the intervals between the training trial and the shock were 30 min and longer, the response failure seen 24 hr after the training trial was incomplete (data not shown). Therefore, the electroconvulsive shock was given immediately after the training trial for the evaluation of test com pounds. DM-9384 at doses of 1 and 3 mg/kg administered 1 hr before the training trial significantly increased % retention, and it tended to prolong test latency without affecting training latency. However, DM 9384 was inactive at doses of 0.3, 10, 30 and 100 mg/kg, indicating that the dose-response curve for this compound was bell-shaped. Aniracetam also showed a similar effect only at 10 mg/kg (Fig. 2) .
Passive avoidance response failure in duced by scopolamine:
After the test trial, the non-scopolamine treated group showed a 93% retention, which was indicative of almost complete task acquisition.
In con trast, in the groups of animals receiving scopolamine 15 min before training at doses of 0.1, 0.3 and 1.0 mg/kg, i.p., % retention was reduced to 87, 33 and 7%, respectively. Test latency was also decreased dose dependently, but training latency was un changed. In addition, there was a tendency for % retention and test latency to decrease when the 1.0 mg/kg, i.p.-dose of scopolamine was given 15 min before the test trial. On the other hand, 1 mg/kg of scopolamine, i.p., administered immediately after training failed to affect these parameters (Fig. 3) . Thus, the administration of the 1 mg/kg dose of scopolamine 15 min before the training trial was essential to achieve almost complete passive avoidance response failure. At this dose, the pain threshold to foot shock was unchanged as measured by the latency in vocalization after exposure to foot shock, although a transient increase in spontaneous motor activity was observed.
Accordingly, this response impairment was not due to its anti-nociceptive effect. In the present experi ment, therefore, 1 mg/kg of scopolamine was for evaluating the drug effect. DM-9384 at 0.3 and 100 mg/kg did not improve this task, but at 1, 10 and 30 mg/kg, it significantly ameliolated the reduction in % retention, although the test latency was sig nificantly prolonged at 10 mg/kg. The dose response relationship was bell-shaped, the maximal effect being 67% at 10 mg/kg (Fig.  4) . Aniracetam at doses of 1, 10 and 30 mg/kg caused significant increases in % retention (33%) and showed a tendency to increase test latency, suggesting that the effect of aniracetam was somewhat less potent than that of DM-9384. Arecoline, a cholinergic agonist, was without effect at a dose of 1.25 mg/kg, i.p., while the doses of 2.5 and 5.0 mg/kg, i.p., were found to increase % retention and test latency. Shuttle box active avoidance task: The rats treated with DM-9384 at a repeated dose of 10 mg/kg/day for 7 days exhibited a sig nificantly higher daily acquisition of avoidance rate during the 2nd to 5th session than did the vehicle control group. With respect to the number of intertrial responses, no significant difference between DM-9384 and control groups was observed except at the 1st session. Interruption of DM-9384 adminis tration had no influence on the avoidance and intertrial responses (Fig. 5) . DM-9384 at doses of 1 and 3 mg/kg exerted no effect on both parameters (data not shown). Light-dark discrimination learning with positive reinforcement: Figure 6 shows the time course of acquired % correct response in the vehicle and DM-9384 treated groups. In the control group, the correct response rate at the 1 st session was 36% (number of correct and incorrect responses was 23.3±3.5 and 40.3±2.4, respectively), then gradually in creased to reach a level of 85% or greater at the 18th to 20th sessions (numbers of correct and incorrect responses were 51.8± 2.0 and 9.0±2.9, respectively). The group treated with DM-9384 at a dose of 3 mg/kg/ day for 25 days showed 41.7% of correct response rate in the 1st session and reached the 85% level in the 14th session, showing a tendency for the learning to be acquired more rapidly as compared to the control group. The correct response rate in the 1 st session of the 10 mg/kg group was 43.7%, and the response rates in the 2nd and 4th sessions were significantly higher than that of the control group, although it took 17 days to reach the criterion of 85%. The correct response rate in the 1st session and the time course of the 30 mg/kg group were almost the same as those of the 3 mg/kg group. No remarkable changes in general behavior of animals receiving DM-9384 were evident throughout the experimental period.
Discussion
The results of the present study in rats confirm and extend the preliminary report (1) that DM-9384 is capable of ameliorating electroconvulsive shock-induced amnesia in mice. In the step-through passive avoidance response failure induced by electroconvulsive shock, DM-9384, like aniracetam, improved the amnesia when administered 1 hr before the training trial, and the potency of DM 9384 was estimated to be 3-10 times as strong as that of aniracetam. Since the electro convulsive shock was applied immediately after the training trial in the present study, the amnesia appears to be caused by interfering with memory consolidation as pointed out by several investigators (2-5). Therefore, these compounds were considered to exert their antiamnesic effect through affecting this process of memory.
Another amnesic model used in this study was scopolamine-induced amnesia in which it was given 1 5 min before passive avoidance training. Concerning this amnesia, however, there has been considerable inconsistency in the literature with respect to the incidence and severity of the model. Cumin et al. (6) proposed that scopolamine injected im mediately after the training trial produced failure of the passive avoidance task 2-3 hr later, while Yamamura et al. (7) reported such a procedure did not induce amnesia. In our experimental conditions, amnesia was achieved only when scopolamine was given either before the training trial or before the test trial. These results may be interpreted as suggesting that the amnesic agent seems to disturb both the acquisition and retrieval processes of memory. As in the electro convulsive shock model, DM-9384 adminis tered before the training trial was also found to be effective against this task and might principally protect the animals from the disturbance of the acquisition process. Ani racetam also induced a similar but somewhat weaker effect. Furthermore, the muscarinic agonist arecoline showed an antiamnesic effect, suggesting the possible involvement of cholinergic mechanisms in the development of this amnesic model. Since it is well-known that cholinergic agonists like arecoline facilitate learning behavior (8-11 ), the present results demonstrate the proprieties of the method used in this study. The dose-response curves for DM-9384 and aniracetam in both electroconvulsive shock and scopolamine induced amnesia were bell-shaped. The reason for this particular dose-effect function is obscure at the present time, although several investigators have reported such a type of dose response-relationship with other drugs that are thought to enhance cognitive functions (6, 12-17).
The results described above prompted us to examine whether or not DM-9384 facilitates the acquisition process of more complicated learning. At first we attempted to explore its effect on the acquisition of active avoidance response. As a result, DM 9384 administered 1 hr before each session significantly enhanced the daily acquisition rate from the 2nd session, and the rate reached to the 80% criterion level more rapidly than in the vehicle control group. It exerted almost no effect on the inter-trial shuttle number. In addition, cessation of DM 9384 medication for a few days after arrival to the 80% level had no influence on the acquired avoidance rate. These results provide evidence that the facilitatory effect of this compound on the acquisition process is not secondary to the enhancement of the motor function.
In view of the negative reinforcement used in all the paradigms described above, an additional experiment was performed in an attempt to examine the effect of DM-9384 on learning behavior with positive reinforcement. In the present experiment, the light-dark discrimination method described by Nomura (18) was modified and employed as such a paradigm. This compound administered im mediately after each session at doses of 3, 10 and 30 mg/kg/day slightly increased the acquisition of correct responses. Especially at a dose of 3 mg/kg, the correct response rate reached the 85% level somewhat more rapidly than did the vehicle treated control group. Since the learning task with negative re inforcement is associated with emotional responses in general, this light-dark task with positive reinforcement is considered to be suitable for evaluating more specifically the drug effect on learning. Considering these points, it is unlikely that the cognitive enhancing effect of DM-9384 is mediated through an emotional reaction.
According to the kinetic studies in rats (K. Sudo, unpublished data), the biological half life of DM-9384 in the blood was 2.3 hr and almost 90% of the compound was excreted into urine and feces within 24 hr. With respect
